Click here for Vyndaqel®▼ (tafamidis) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
A Disease Enigma: Unlocking the Clinical Clues of ATTR-CM
Dr Pablo Garcia-Pavia provides an overview of ATTR-CM and the initial patient presentation. He presents at the live Crack the Code: Unmasking and Addressing ATTR-CM in Your Practice webinar in 2020.
Challenging Case of Heart Failure: Putting the Clues of ATTR-CM Together
Claudio Rapezzi discusses what should prompt suspicion of ATTR-CM in this patient and how suspicion can be confirmed through diagnostic techniques.
Cracked the Code: What to Do Next? A Treatment Option for Patients with ATTR-CM
Dr Thibaud Damy reviews the clinical data for a treatment option for ATTR-CM.
Faces and Cases: Recognising ATTR-CM across the spectrum of patients
Michelle Michels takes us through three patient cases and shows us the faces and cases in order to recognise ATTR Cardiomyopathy in everyday clinic.
Identifying ATTR-CM: The need for early diagnosis
Fabian Knebel highlights the importance of an early diagnosis of ATTR-CM when presenting at the ESC Industry On-Demand Q /A Session 2020.
Diagnosing ATTR-CM: Using the right tool at the right time
Oliver Lairez presents the tools to diagnose ATTR-CM, which was taken from the ESC Industry On-Demand Q /A Session 2020.
Future directions for management of cardiac amyloidosis
This is the recorded speaker session from the BSH Pfizer-sponsored Symposium which took place on the 26-27th November 2020. Lisa Anderson discusses the diagnosis and early management of cardiac amyloidosis and Rob Cooper takes you through the emerging treatment strategies for cardiac amyloidosis.
See other educational resources available
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. October 2020
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020